Hogan Lovells has advised HLS Therapeutics Inc. on the deal. HLS Therapeutics Inc. (TSX: HLS) sold its royalty interest and milestone payment obligations in the global...
DRI Healthcare Trust’s Acquisition Of XENPOZYME From HLS Therapeutics Inc.
Sartorius Group’s Agreement And Minority Investment With TheWell Bioscience Inc.
Hogan Lovells acted for Sartorius on the deal. The life science group Sartorius and U.S.-based startup TheWell Bioscience have agreed to partner on the further development...
Cygna Labs’ Acquisition of the VitalQIP Product From Nokia
Hogan Lovells advised Cygna Labs Group on the acquisition of the VitalQIP product from Nokia. The agreement also includes the associated intellectual property and certain customer...
Beijer Ref AB’s US$1.275 Billion Acquisition of Heritage Distribution Holdings
Hogan Lovells advised Beijer Ref AB on the deal. Mannheimer Swartling acts as legal advisor to Beijer Ref in relation to the debt financing and rights...
Cygna Labs Group’s Acquisition of Diamond IP From BT
King & Wood Mallesons and Hogan Lovells advised Cygna Labs Group on the deal. Cygna Labs, a highly specialized software manufacturer with a focus on providing...